TUG-1375
CAS No. 2247372-59-2
TUG-1375( —— )
Catalog No. M21070 CAS No. 2247372-59-2
TUG-1375 is an Agonist of Thiazolidine Free Fatty Acid Receptor 2.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 305 | Get Quote |
|
| 10MG | 500 | Get Quote |
|
| 25MG | 779 | Get Quote |
|
| 50MG | 1044 | Get Quote |
|
| 100MG | 1404 | Get Quote |
|
| 500MG | 2808 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameTUG-1375
-
NoteResearch use only, not for human use.
-
Brief DescriptionTUG-1375 is an Agonist of Thiazolidine Free Fatty Acid Receptor 2.
-
DescriptionTUG-1375 is an Agonist of Thiazolidine Free Fatty Acid Receptor 2.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorFFA2
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2247372-59-2
-
Formula Weight442.92
-
Molecular FormulaC22H19ClN2O4S
-
Purity>98% (HPLC)
-
SolubilityDMSO:125 mg/mL (282.22 mM)
-
SMILESCc1noc(C)c1-c1ccc(C(=O)N2C(C(=O)O)CSC2c2ccccc2Cl)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Hansen Anders H?jgaard Sergeev E Bolognini D et al. Discovery of a Potent Thiazolidine Free Fatty Acid Receptor 2 Agonist with Favorable Pharmacokinetic Properties[J]. Journal of Medicinal Chemistry 2018.
molnova catalog
related products
-
Labetuzumab
Labetuzumab is a humanized anti-carcinoembryonic antigen (CEA) monoclonal antibody with anticancer activity that inhibits tumor growth and is used in the study of thyroid and colorectal cancer (CRC).
-
10-Methoxygambogenic...
10-Methoxygambogenic acid is highly cytotoxic to HL-60, SMMC-7721 and BGC-83 cells.
-
C-Peptide 2 (rat)
C-Peptide 2, rat, 31-amino-acid peptide, is a component of proinsulin. C-Peptide 2, rat can inhibit glucose-induced insulin secretion.
Cart
sales@molnova.com